{"id":285598,"date":"2016-12-18T02:44:04","date_gmt":"2016-12-18T01:44:04","guid":{"rendered":"http:\/\/rinf.com\/alt-news\/newswire\/embattled-epipen-maker-launches-cheaper-alternative\/"},"modified":"2016-12-18T17:08:04","modified_gmt":"2016-12-18T16:08:04","slug":"embattled-epipen-maker-launches-cheaper-alternative","status":"publish","type":"post","link":"http:\/\/rinf.com\/alt-news\/newswire\/embattled-epipen-maker-launches-cheaper-alternative\/","title":{"rendered":"Embattled EpiPen maker launches cheaper alternative"},"content":{"rendered":"<p>Mylan NV, the much-scrutinized manufacturer of emergency allergy injector EpiPen, has released a generic alternative to EpiPen at half the price of the branded product, $300 for a two-pack.<\/p>\n<div>\n<p>Mylan is releasing a generic version of EpiPen, which will be identical to the original, according to reports. EpiPen costs $600 for a two-pack, at least a 500 percent increase from its the price in 2007, though cost savings on the generic version will likely depend on insurance and other provisions, according to the Associated Press.<\/p>\n<p>Mylan has come under fire as of late for <a href=\"https:\/\/www.rt.com\/usa\/358460-epipen-maker-investigation-price-hike\/\">price hikes<\/a> of EpiPen, a vital device for people suffering from a life-threatening allergic reaction known as anaphylactic shock, which requires immediate treatment.<\/p>\n<p>The company also allegedly <a href=\"https:\/\/www.rt.com\/usa\/360084-epipen-medicare-medicaid-scam\/\">defrauded Medicaid<\/a> over its EpiPen products, all of which has put the company in the crosshairs of state and federal investigations into alleged price-fixing by several drug makers. On Thursday, 20 states <a href=\"https:\/\/www.rt.com\/usa\/370450-drug-companies-lawsuit-price-fixing\/\">filed a lawsuit<\/a> against six drug companies, including Mylan, for alleged price collusion.<\/p>\n<p>EpiPen syringes are filled with the hormone epinephrine, which expires after a year. Many schools, workplaces, and other venues are forced to turn to EpiPen, given its competitors, AUVI-Q and TwinJect, have recently recalled their injectors over issues with dosages or devices. Another competitor, Impax Laboratories, <a href=\"https:\/\/www.rt.com\/usa\/357560-mylan-generic-epipen-cost\/\">said<\/a> earlier this year that it could not produce its Adrenaclick injector in large quantities.<\/p>\n<p>Thus, Mylan&#8217;s price hikes in recent years have drawn outrage from consumers <a href=\"https:\/\/www.rt.com\/usa\/356884-epipen-price-hike-congress\/\">and the US Senate<\/a> alike. <a href=\"https:\/\/www.rt.com\/usa\/367740-epipen-settlement-senate-testify\/\">Last month<\/a>, Mylan refused to send a representative to a Senate committee hearing over its potential settlement with the federal government for the company&#8217;s alleged overcharging of Medicaid.<\/p>\n<p>Mylan has blamed high costs of EpiPen on insurance companies and other facets of health care in the US.<\/p>\n<p><em>&#8220;All involved must also take steps to help meaningfully address the US healthcare crisis, and we are committed to do our part to drive change,\u201d<\/em> company CEO Heather Bresch <a href=\"https:\/\/www.rt.com\/usa\/357200-epipen-price-outrage-clinton\/\">said<\/a> in an August statement.<\/p>\n<p>Mylan said discounts for EpiPen that it <a href=\"https:\/\/www.rt.com\/usa\/357200-epipen-price-outrage-clinton\/\">announced <\/a>in August will apply to the generic version, according to AP.<\/p>\n<p><iframe loading=\"lazy\" src=\"https:\/\/www.youtube.com\/embed\/5n7Ti2wCcfA\" width=\"854\" height=\"480\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<\/div>\n<p>Via <a href=\"https:\/\/www.rt.com\/usa\/370582-mylan-epipen-generic-version\/?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=RSS\">RT<\/a>. This piece was reprinted by <a href=\"http:\/\/rinf.com\">RINF Alternative News<\/a> with permission or license.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mylan NV, the much-scrutinized manufacturer of emergency allergy injector EpiPen, has released a generic alternative to EpiPen at half the price of the branded product, $300 for a two-pack. Mylan is releasing a generic version of EpiPen, which will be identical to the original, according to reports. EpiPen costs $600 for a two-pack, at least [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":278496,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[519],"tags":[],"class_list":{"0":"post-285598","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-newswire"},"_links":{"self":[{"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/posts\/285598","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/comments?post=285598"}],"version-history":[{"count":0,"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/posts\/285598\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/media\/278496"}],"wp:attachment":[{"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/media?parent=285598"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/categories?post=285598"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/tags?post=285598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}